Update on infections caused by Staphylococcus aureus

References

• Ben Ayed, S., I. Boutiba-Ben Boubaker, E. Samir, and S. Ben Redjeb. 2006. Prevalence of agr specificity groups among methicilin resistant Staphylococcus aureus circulating at Chales Nicole hospital of Tunis. Pathologie Biologie 54:435–438.
   Google Scholar
• Bogeart, D., A. van Belkum, M. Sluijter, A. Luidendijk, R. de Groot, H. C. Rumke, HA. Verbrugh, and P. W. M. Hermans. 2004. Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet 363
   Google Scholar
• Boucher, H., L Miller, and R. Razonable. 2010. Serious infections caused by methicillin-resistant Staphylococcus aureus. Clinical Infectious Diseases 51 (Supl 2):S183–S197.
   Google Scholar
• Cosgrove, S. E., G. Sakoulas, E. N. Perenecevich, M. J. Schwaber, A. W. Karchmer, and Y Canneli. 2003. Comparison of mortaRty associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clinical Infectious Diseases 36.
   Google Scholar
• Cotton, M. F., E. Wasserman, J. Smit, A. Whitelaw, and H. J. Zar. 2008. High incidence of antimicrobial resistant organisms including extended spectrum beta-lactamase producing Enterobactedaceae and methicillin-resistant Staphylococcus aureus in nasopharyngeal and blood isolates of HIV-infected children from Cape Town, South Africa. BMJ Infectious Diseases 8:40.
   Google Scholar
• Deurenberg, R. H., C. Vink, S. Kalenic, A. W. Friedrich, C. A. Bruggeman, and E. E. Stobberingh. 2006. The molecular evolution of methicillin-resistant Staphylococcus aureus. Clinical Microbiology and Infection 13:222–235.
   Google Scholar
• Gresham, H. D., J. H. Lowrance, T. E. Gayer, B. S. Wilson, A. L Cheung, and F. P. Lindberg. 2000. Survival of Staphylococcus aureus inside neutrophils contributes to infection. The Journal of Immunology 164:3713–3722.
   Google Scholar
• Harbarth, S., O. Rutschmann, P. Sudre, and D. Nttet. 1998. Impact of methicillin resistance on the outcome of patientswith bacteremia caused by Staphylococcus aureus. Archives of Internal Medicine 158:182–189.
   Google Scholar
• Haslinger-Loffler, B., B. C. Kahl, M. Grundmeier, K. Strangfeld, B. Wagner, U. Fischer, A. L. Cheung, G. Peters, K. Schulze-Osthoff, and B. Sinha. 2005. Multiple virulence factors are required for Staphylococcus aureus-induced apoptosis in endothelial cells. Cellular Microbiology 7(8):1087–1097.
   Google Scholar
• Jansen van Rensburg, MV. Eliya Madikane, A. Whblaw, M. Chachage, S. Haffejee, and B. Elisha. 2010. The dominant methicillin-resistant Staphylococcus aureus clone from hospitals in Cape Town has an unusual genotype: ST612. Clinical Microbiology and Infection.
   Google Scholar
• Jarraud, S., C. Mougel, J. Thioulouse, G. Lina, H. Meugnier, E Forey, X. Nesme, J. Etienne, and F Vandenesch. 2002. Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles) and human disease. Infection and Immunity 70:631–641.
   Google Scholar
• Jarvis, W. R. 1998. Epidemiology, appropriateness, and cost of Vancomycin use. Clinical Infectious Diseases 26:1200–1203.
   Google Scholar
• Kirst, H. A., D. G. Thompson, and N. T. I. 1998. Historical yearly use of vancomycin. Antimicrobial Agents and Chemotherapy 42:1303–1304.
   Google Scholar
• Kluytmans, J., A. van Belkum, and H. Verbrugh. 1997. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clinical Microbiology Reviews 10:505–520.
   Google Scholar
• Korem, MY. Gov, M. D. Kiran, and N. Balaban. 2005. Transcriptional profiling of target of RNAIII-activating protein, a master regulator of staphylococcal virulence. Infection and Immurty 73:6220–6228.
   Google Scholar
• Makgotlho, P. E., M. M. Kock, A. Hoosen, R. Lekalakala, S. Omar, M. Dove, and M. M. Ehlers. 2009. Molecular identification and genotyping of MRSA isolates. FEMS Immunol Med Mecrobiol 57.
   Google Scholar
• Melles, D., E. Pauw, L. van den Boogaard, H. Boelens, J. Peters, J. Peeters, H. Whenboer, W. van Leeuwen, H. Verbrugh, A. van Belkum, and J. Nouwen. 2008. Host-microbe interplay in persistent Staphylococcus aureus nasal carriage in HIV patients. Microbes and Infection 10:151–158.
   Google Scholar
• Millar, B., A. Loughrey, J. Elborn, and J. Moore. 2007. Proposed definitions of community-associated meticillin-resistant Staphylococcus aureus (CA-MRSA). Journal of Hospital Infection 67:109–113.
   Google Scholar
• Moodley, A., W. F. Oosthuysen, A. G. Duse, and E. Marais. 2010. Molecular characterization of clinical Methicillin-Resistant Staphylococcus aureus in South Africa. Journal of Clinical Microbiology.
   Google Scholar
• Naber, C. K. 2009. Staphylococcus aureus bacteremia: epidemiology, pathopysiology, and management strategies. Clinical Infectious Diseases 48:231–237.
   Google Scholar
• Nimmo, G. R., and W. Coombs. 2008. Community associated methicillin-resistant Staphylococcus aureus (MRSA) in Australia. International journal of Antimicrobial Agents 31:401–410.
   Google Scholar
• Nouwen, J., A. Ott, M. Kluytmans-Vandenbergh, H. Boelens, A. Hofman, A. van Belkum, and H. Verbrugh. 2004. Predicting the Staphylocuccus aureus nasal carrier state: derivation and validation of a “culture rule”. Clinical Infectious Diseases 39:806–11.
   Google Scholar
• Plata, K., A. Rosato, and G. Wegrzyn. 2009. Staphylococcus aureus as an infectious agent: overview of biochemistry and molecular genetics of its pathogenicity. Ada Biochimica Polonia 56:597–612.
   Google Scholar
• Popovich, K., R. Weinstein, and B. Hota. 2007.Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? Clinical Infectious Diseases 46:787–794.
   Google Scholar
• Sakoulas, G., PA. Moise-Broder, J. Schentag, A. Forrest, R. C. J. Moellering, and G. M. Eliopoulos. 2004. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. Journal of Clinical Microbiology 42:2398–2402.
   Google Scholar
• Salgado, C., B. Farr, and D. Dalfee. 2003. Commurty-acquired methicillin resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clinical Infectious Diseases 36:131–39.
   Google Scholar
• Tong, S., E. Bishop, R. Lilliebridge, A. Cheng, Z. Spasova-Penkova, D. Holt, P. Giffard, M. McDonald, B. Currie, and C. Boutlis. 2009. Community-associated strains of methicillin-resistant Staphylococcus aureus and methicillin susceptible S. aureus in indegenous Norhem Australia: Epidemiology and Outcomes. Journal of Infectious Diseases 199:1461–1470.
   Google Scholar
• van Belkum, A., N. J. Verkaik, C. P. de Vogel, H. A. Boelens, J. Verveer, J. L. Nouwen, H. A. Verbrugh, and H. F. L. Wertheim. 2009. Reclassification of Staphylococcus aureus Nasal Carraige Types. Journal of Infectious Diseases 199:1820–1826.
   Google Scholar
• Vandenesch, F., T. Naimi, M. C. Enright, G. Lina, G. R. Nimmo, H. Heffernan, N. Liassine, M. Bes, T. Greenland, M.-E. Reverdy, and J. Etienne. 2003. Community-acquired methicillin resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerging Infectious Diseases 9:978–984.
   Google Scholar
• von Eiff, C., K. Becker, K. Machka, H. Stammer, and G. Peters. 2001. Nasal carriage as a source of Staphylococcus aureus bacteremia. New England Journal of Medicine 344:11–16.
   Google Scholar
• Walsh, T R., A. Bolmström, A. Qwärnstrom, P. Ho, M. Wootton, R. A. Howe, A. P. MacGowan, and D. Diekema. 2001. Evaluation of Current Methods for Detection of Staphylococci with Reduced Susceptibility to Glycopeptides. Journal of Clinical Microbiology 39:2439–2444
   Google Scholar
• Wertheim, H., D. Melles, M. Vos, W. van Leeuwen, A. van Belkum, H. Verbrugh, and J. Nouwen. 2005. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infectious Diseases 5:751–62.
   Google Scholar
• Wertheim, H., J. Verveer, H. Boelens, A. van Belkum, H. Verbrugh, and M. Vos. 2005. Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults. Antimicrobial Agents and Chemotherapy 49:1456–7.
   Google Scholar
• Wertheim, H., M. Vos, A. Ott, A. van Belkum, A. Voss, J. Kluytmans, P. van Keulen, C. Vandenbroucke-Grauls, M. Meester, and H. Verbrugh. 2004. Risk and outcome of nosocomial Staphylococcus aureus bacteremia in nasal carriers versus non-carders. Lancet 364:703–705.
   Google Scholar
• Wootton, M., R. A. Howe, R. Hillman, T R. Walsh, P. M. Bennett, and A. P. MacGowan. 2001. A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital. Journal of Antimicrobial Chemotherapy 47:399–403.
   Google Scholar